10 likes | 118 Views
Table 1: GATE 2. Advancing a Vaccine Candidate from Preclinical Development to Early Clinical Stage (Phase I/ IIa ) (2.1 Pathway to GMP Manufacturing and pre-clinical toxicology).
E N D
Table 1: GATE 2. Advancing a Vaccine Candidate from Preclinical Development to Early Clinical Stage (Phase I/IIa) • (2.1 Pathway to GMP Manufacturing and pre-clinical toxicology)